美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=EMEND"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EMEND 021549 001 NDA APREPITANT CAPSULE;ORAL 80MG Yes No 2003/03/26 2003/03/26 MERCK Prescription
EMEND 021549 002 NDA APREPITANT CAPSULE;ORAL 125MG Yes Yes 2003/03/26 2003/03/26 MERCK Prescription
EMEND 021549 003 NDA APREPITANT CAPSULE;ORAL 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 2003/03/26 2006/06/30 MERCK Discontinued
EMEND 022023 001 NDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 2008/01/25 2008/01/25 MERCK AND CO INC Discontinued
EMEND 022023 002 NDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL Yes Yes 2008/01/25 2010/11/12 MERCK AND CO INC Prescription
EMEND 207865 001 NDA APREPITANT FOR SUSPENSION;ORAL 125MG/KIT Yes Yes 2015/12/17 2015/12/17 MSD MERCK CO Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database